Samantha Martin, MD

Dr. Samantha Martin was born and raised in Boston and earned her bachelor's degree from Harvard College in Organismic and Evolutionary Biology. She then attended the University of Massachusetts Medical School followed by pediatrics residency training at MGH where she worked with Dr. Lael Yonker examining immunologic activation in pediatric patients with cancer in response to COVID-19 infection and vaccination. As a fellow in the Pediatric Hematology/Oncology Fellowship Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, she is interested in early phase clinical trials of immunotherapies in pediatric solid tumors and is working with Dr. Steven DuBois in developing a clinical trial for naxitamab for patients with relapsed/refractory neuroblastoma. She is also interested in evaluating antibody-drug conjugates for pediatric solid tumors and is working with the Gillani Lab to systematically characterize ADC target expression in this group of diseases and support translation of these therapies into pediatric clinical trials.